PLSM
Pulsenmore Ltd. Ordinary Shares
NASDAQ: PLSM · HEALTHCARE · MEDICAL DEVICES
$3.35
-1.18% today
Updated 2026-05-01
Market cap
$24.06M
P/E ratio
—
P/S ratio
1.78x
EPS (TTM)
$-0.82
Dividend yield
—
52W range
$3 – $2,226
Volume
0.0M
Pulsenmore Ltd. Ordinary Shares (PLSM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | $507831.00 | $3.07M | $1.70M | $2.65M | $40.02M |
| Revenue growth (YoY) | — | — | — | +505.1% | -44.5% | +55.6% | +1409.5% |
| Cost of revenue | $66589.00 | $109007.00 | $441215.00 | $1.95M | $1.69M | $2.08M | $6.34M |
| Gross profit | $-66589.00 | $-109007.00 | $66616.00 | $1.12M | $11016.00 | $568111.00 | $33.68M |
| Gross margin | — | — | 13.1% | 36.5% | 0.6% | 21.4% | 84.2% |
| R&D | $751013.00 | $3.20M | $3.42M | $8.20M | $8.35M | $5.19M | $17.35M |
| SG&A | — | — | $2.87M | $4.86M | $5.28M | $4.72M | $5.52M |
| Operating income | $-1.15M | $-4.13M | $-7.06M | $-13.13M | $-15.31M | $-11.59M | $-12.16M |
| Operating margin | — | — | -1390.2% | -427.2% | -898.3% | -437.0% | -30.4% |
| EBITDA | $-1.18M | $-4.14M | $-7.97M | $-5.82M | $-15.27M | $-9.17M | $-12.73M |
| EBITDA margin | — | — | -1570.1% | -189.3% | -895.7% | -345.7% | -31.8% |
| EBIT | $-1.25M | $-4.25M | $-8.15M | $-6.19M | $-15.93M | $-9.95M | $-15.54M |
| Interest expense | $22582.00 | $29587.00 | $93005.00 | $99175.00 | $168275.00 | $148203.00 | $315000.00 |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.27M | $-4.28M | $-8.25M | $-6.29M | $-16.13M | $-10.08M | $-15.85M |
| Net income growth (YoY) | — | -236.2% | -92.8% | +23.8% | -156.6% | +37.5% | -57.2% |
| Profit margin | — | — | -1623.9% | -204.5% | -946.5% | -380.3% | -39.6% |